Back to trial details

Intake questionnaire

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Applying to University of Chicago Comprehensive Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Extensive Stage Lung Small Cell Carcinoma?
3. Are you able to travel to Chicago for study visits?